Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditions.

Kawasaki acute flaccid paralysis adverse event following immunisation bloodstream infections child encephalitis group A streptococcus hospital influenza intussusception meningococcal pertussis surveillance vaccine preventable diseases varicella zoster virus paediatric

Journal

Communicable diseases intelligence (2018)
ISSN: 2209-6051
Titre abrégé: Commun Dis Intell (2018)
Pays: Australia
ID NLM: 101735394

Informations de publication

Date de publication:
30 09 2021
Historique:
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 26 10 2021
Statut: epublish

Résumé

The Paediatric Active Enhanced Disease Surveillance (PAEDS) network is an Australian hospital-based active surveillance system employing prospective case ascertainment for selected serious childhood conditions, particularly vaccine preventable diseases and potential adverse events following immunisation (AEFI). This report presents surveillance data for 2019. Specialist nurses screened hospital admissions, emergency department records, laboratory and other data on a daily basis in seven paediatric tertiary referral hospitals across Australia, to identify children with the conditions under surveillance. Standardised protocols and case definitions were used across all sites. In 2019, the conditions under surveillance comprised: acute flaccid paralysis (AFP; a syndrome associated with poliovirus infection), acute childhood encephalitis (ACE), influenza, intussusception (IS; a potential AEFI with rotavirus vaccines), pertussis, varicella-zoster virus infection (varicella and herpes zoster), invasive meningococcal and invasive Group A streptococcus diseases and two new conditions, Kawasaki disease and gram-negative bloodstream infections. An additional social research component continued to evaluate parental attitudes to influenza vaccination. PAEDS captured 2,701 cases for 2019 across all conditions under surveillance. Key outcomes of PAEDS included: contribution to national AFP surveillance to reach the World Health Organization reporting targets for detection of poliomyelitis cases; demonstration of high influenza activity in 2019 and influenza-associated deaths in ACE cases; identification of key barriers to influenza vaccination of children hospitalised for acute respiratory illness; reporting of all IS cases associated with vaccine receipt to relevant state health department; and showing a further reduction nationally in varicella cases. Enhanced pertussis surveillance continued to capture controls to support vaccine efficacy estimation. Invasive meningococcal disease surveillance showed predominance of serotype B and a reduction in cases nationally. Surveillance for invasive group A streptococcus captured severe cases in children. Monitoring of Kawasaki disease incidence and gram-negative bloodstream infections commenced. PAEDS continues to provide unique policy-relevant data on serious paediatric conditions using sentinel hospital-based enhanced surveillance. Keywords: paediatric, surveillance, child, hospital, vaccine preventable diseases, adverse event following immunisation, acute flaccid paralysis, encephalitis, influenza, intussusception, pertussis, varicella zoster virus, meningococcal, group A streptococcus, Kawasaki, bloodstream infections.

Identifiants

pubmed: 34587877
doi: 10.33321/cdi.2021.45.53
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Commonwealth of Australia CC BY-NC-ND.

Auteurs

Nicole Dinsmore (N)

National Centre for Immunisation Research and Surveillance (NCIRS), Kids Research Institute, The Children's Hospital at Westmead.

Jocelynne E McRae (JE)

National Centre for Immunisation Research and Surveillance (NCIRS), Kids Research Institute, The Children's Hospital at Westmead.
Discipline of Child and Adolescent Health – Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales

Helen E Quinn (HE)

Senior Research Fellow, National Centre for Immunisation Research and Surveillance, Kids Research Institute, The Children’s Hospital at Westmead, New South Wales
Faculty of Medicine and Health, University of Sydney, New South Wales

Catherine Glover (C)

National Centre for Immunisation Research and Surveillance, Kids Research Institute, The Children’s Hospital at Westmead, New South Wales

Sonia Dougherty (S)

Queensland Children’s Hospital, Brisbane, Queensland

Alissa McMinn (A)

Murdoch Children’s Research Institute, SAEFVIC, Victoria

Nigel Crawford (N)

Murdoch Children’s Research Institute. Honorary Principal Fellow, Department of Paediatrics, University of Melbourne, Victoria

Helen Marshall (H)

Vaccinology and Immunology Research Trials Unit, Women and Children’s Hospital, Adelaide, South Australia

Samantha J Carlson (SJ)

School of Public Health, Faculty of Medicine and Health, University of Sydney, New South Wales

Christopher Blyth (C)

Infectious Diseases Department, Perth Children’s Hospital, Perth, Western Australia
Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth, Western Australia

Ryan Lucas (R)

Discipline of Child and Adolescent Health – Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales
Department of General Medicine – The Children’s Hospital at Westmead, Sydney, New South Wales

Adam Irwin (A)

Senior Lecturer in Paediatric Infectious Disease, The University of Queensland, UQ Centre for Clinical Research, Queensland

Kristine Macartney (K)

Faculty of Medicine and Health, University of Sydney, New South Wales
National Centre for Immunisation Research and Surveillance, Kids Research Institute, The Children’s Hospital at Westmead, New South Wales
Department of Infectious Diseases & Microbiology, The Children’s Hospital at Westmead, Sydney, New South Wales
Discipline of Child and Adolescent Health, University of Sydney, New South Wales

Nicholas Wood (N)

Faculty of Medicine and Health, University of Sydney, New South Wales
National Centre for Immunisation Research and Surveillance (NCIRS), Sydney, New South Wales
Clinical school, Child and Adolescent Health, University of Sydney, New South Wales

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH